The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
Clinical trial NCT04985968 · TERMINATED
Trial details
- NCT number
- NCT04985968
- Sponsor
- InDex Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2023-12-20
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.